MedPath

Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd. logo
🇹🇼Taiwan
Ownership
Public
Established
2013-01-01
Employees
51
Market Cap
-
Website
http://www.foreseepharma.com

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer

Phase 3
Completed
Conditions
Prostatic Neoplasms
Interventions
First Posted Date
2017-08-25
Last Posted Date
2020-05-04
Lead Sponsor
Foresee Pharmaceuticals Co., Ltd.
Target Recruit Count
144
Registration Number
NCT03261999
Locations
🇱🇹

Klaipėda University Hospital, Klaipėda, Lithuania

🇱🇹

National Cancer Institute, Vilnius, Lithuania

🇸🇰

Fakultná nemocnica s poliklinikou Žilina Urológia, Žilina, Slovakia

and more 18 locations

Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg

Phase 3
Completed
Conditions
Prostatic Neoplasms
Interventions
Drug: LMIS 50 mg
First Posted Date
2016-03-18
Last Posted Date
2019-03-26
Lead Sponsor
Foresee Pharmaceuticals Co., Ltd.
Target Recruit Count
30
Registration Number
NCT02712320
Locations
🇺🇸

Urology Centers of Alabama, Homewood, Alabama, United States

🇺🇸

Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States

🇺🇸

Idaho Urologic Institute - Meridian, Meridian, Idaho, United States

and more 4 locations

Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2014-09-12
Last Posted Date
2022-08-08
Lead Sponsor
Foresee Pharmaceuticals Co., Ltd.
Target Recruit Count
80
Registration Number
NCT02238834
Locations
🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Phase 3
Completed
Conditions
Prostatic Neoplasms
Interventions
First Posted Date
2014-09-09
Last Posted Date
2019-03-05
Lead Sponsor
Foresee Pharmaceuticals Co., Ltd.
Target Recruit Count
137
Registration Number
NCT02234115
Locations
🇺🇸

Idaho Urologic Institute - Meridian, Meridian, Idaho, United States

🇺🇸

Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States

🇨🇳

China Medical University Hospital (CMUH), Taichung City, Taichung, Taiwan

and more 26 locations
© Copyright 2025. All Rights Reserved by MedPath